Deepak Fertilisers & Petrochemicals Corp Ltd Q4 FY2024 Concall Summary

Key Takeaways

• Triple headwind, resilient margin: All three businesses faced rare simultaneous shocks (Russian TAN dumping, Chinese Nitroaromatics, drought), yet Q4 EBITDA margin held at 21%, among the highest in five years barring the exceptional FY22.
• TAN imports collapsed, removing the biggest drag: Russian export bans and weak fertilizer demand have driven cheap fertilizer-grade ammonium nitrate imports virtually to zero, setting up a materially improved FY25 for the mining chemicals business.
• Ammonia plant stabilized and profitable at trough pricing: The plant passed its guaranteed test run, runs at rated capacity with best-in-class efficiency, and delivered a PBT-level profit in Q4 despite ammonia prices of only \$410–\$425.
• Two large projects funded and on track for H2 2026: The Gopalpur TAN expansion (\~₹2,200 crores) and Dahej nitric acid project (\~₹1,950 crores) are both financed and targeting commercialization in the second half of 2026, with the nitric acid capacity already substantially underwritten by a customer.
• What to watch next quarter: Whether the monsoon delivers as forecast and lifts crop nutrition utilization toward 60–70%, whether ammonia prices recover to the guided \$400–\$450 range from Q3, and whether the TAN export quota is relaxed beyond the current 20,000 tons.

The Triple Headwind and the Margin Floor

• All three businesses hit simultaneously: Mining chemicals absorbed dumped Russian fertilizer-grade ammonium nitrate, industrial chemicals faced cheap Chinese Nitroaromatics that idled downstream customers, and crop nutrition suffered low, erratic rainfall alongside government price and product micromanagement. Management called the triple effect "rather rare."
• Two one-time financial hits compounded the operating pressure: A large subsidy impact of ₹267 crores taken in H1 and ammonia plant stabilization costs weighed on reported numbers.
• Q4 margin held at 21% despite it all: That level is among the highest in the last five years, exceeded only by the 24% posted in the unusually favorable FY22. Management frames this as evidence of structural resilience rather than cyclical luck.
• TAN profitability variability is contained: Outside the FY22–23 aberration, margins have moved within a 100 bps band, and management expects stability with an improving trend.

Sailesh Mehta: "if you were to ask me in one word to explain the year that went by and our operations, the only word that comes to my mind is resilience, that our businesses have shown great resilience to all the headwinds that we face."

TAN: The Import Threat Has Collapsed

• Cheap Russian imports are virtually at zero: The Russian government banned exports from St. Petersburg due to war-related explosive-material risk, lower rains weakened the domestic fertilizer pull that had absorbed those volumes, and urea and ammonium sulfate emerged as surrogates. Management believes this import pressure will not recur on a year-on-year basis.
• Exports resumed in March 2024 after the ban lifted: The current quota stands at 20,000 tons for the year, and the company expects the government to relax it to allow materially higher exports.
• Demand tailwinds are structural: Coal mining, power, and infrastructure sectors are expected to grow 10–12% in FY25, directly driving TAN consumption.
• The Gopalpur expansion adds volume to a tightening market: The project is underway, with roughly one-third of the total cost already incurred, debt lines tied up, and equity being deployed as needed. Commercialization is targeted for H2 2026.

Deepak Rastogi: "There is always a variability between 100 basis point plus/minus, but it has moved within that range. So, we expect to be stable and continue to be in an improving trend."

Ammonia Plant: Stabilized, Efficient, and Profitable at the Cycle Trough

• The plant cleared its performance guarantee test run and is now running at 100%+ of design capacity, meeting all design norms with globally best efficiency metrics. Management says it is capable of running even higher.
• Profitability arrived despite depressed pricing: Ammonia prices were in the \$410–\$425 range during Q4, yet the plant reported a profit at the PBT level. Management expects prices to recover to \$400–\$450 from Q3 onward, which would widen margins further.
• Volume risk is minimal: Almost 80% of output is captively consumed, so offtake is assured. The plant can handle more volume if needed.
• The investment is judged over decades, not quarters: Management explicitly frames the plant as a 20–25-year asset where quarterly volatility is expected but long-term returns are the thesis.
• State incentives have begun accruing: The PCL ammonia plant received its eligibility certificate and has started the process of claiming incentives, with the payout pace partly tied to ammonia price movements (higher prices accelerate reimbursement).

Deepak Rastogi: "we have actually invested this plant for 20, 25 years. So, this is not a quarter-on-quarter investment or year-on-year investments. And some quarters may be very, very good. Some quarters may not be too good. But from an overall financial perspective, the plant will obviously be making money over a period of time."

Industrial Chemicals: Nitric Acid and the China-Led Margin Squeeze

• Nitric acid faced a double hit in Q4: An extended shutdown at the Dahej plant constrained volumes, while downstream demand stayed subdued because customers found cheaper Nitroaromatics imports from China more attractive than running their own capacity.
• The Chinese dumping cycle has turned: Chinese producers exported aggressively when domestic demand vanished, but those days are over. Imports into India have come down and pricing has stabilized.
• Margins were under pressure but not crushed: Management described the margin compression as "not so bad or rather not so depressed," though logistics costs rose due to Red Sea and European war-zone disruptions.
• Capacity utilization runs near 100% in normal conditions: Last year's dip was driven by plant shutdowns, particularly in Q4, not by structural demand weakness.
• The new nitric acid project is de-risked by a customer underwrite: A large portion of the capacity is already committed under a long-term contract, and the project remains on track for H2 2026 commercialization.
• IPA (RGP-based) is expected to keep performing well on both demand and pricing.

Crop Nutrition: Waiting on the Monsoon

• Q4 was hit by low and irregular rainfall that damaged the rabi crop, with some states experiencing near-drought conditions. Bulk fertilizer margins also suffered from the ₹267 crore subsidy impact booked in H1.
• The IMD is forecasting a good monsoon, which management expects will support all sectors but especially crop nutrition. Utilization, currently depressed, should rise to 60–70% depending on the quarter, and could go higher.
• The Haifa alliance adds a specialty layer: A 7-year strategic commercial alliance with Haifa, a global leader in specialty fertilizers, was signed during the year, supporting the stated drive from commodity to holistic solutions.

Balance Sheet, Funding, and the Unanswered Questions

• Both mega-projects are fully financed: The Gopalpur TAN project (\~₹2,200 crores) has bank approvals and lines in place, with part debt already drawn and equity deployed as needed. The Dahej nitric acid project (\~₹1,950 crores) has bridge funding arranged. Roughly 40% of the nitric acid project cost is expected to be incurred in the current year.
• Credit ratings are reaffirmed at high levels: ICRA reaffirmed DFPCL and MAL at AA- long-term (stable outlook) and A1+ short-term (highest). CRISIL assigned A1+ short-term ratings to both entities.
• Management declined to quantify peak debt: When asked what consolidated debt would top out at post-completion of both projects, the answer was only that the company would be "in a very comfortable zone" and that rating agencies and banks have reviewed the numbers.
• No encumbrance on promoter holdings as of March 31, 2024. The board recommended an 85% dividend (₹8.50 per share).
• Realty asset increase was a reclassification, not new investment: The ₹120 crore sequential rise in realty assets reflected a transfer from unallocated to the realty segment, not fresh capital deployment.
• Other income was boosted by a Vashi asset sale, clubbed under unallocable rather than chemicals.

Guidance & Commitments

Key Metrics